mazindol has been researched along with Metabolic Syndrome in 2 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Because obesity is highly stigmatized, any effective treatment should be made available to improve quality of life and self-image." | 2.47 | Pharmacology in health foods:merits and demerits of food with health claims for the prevention of metabolic syndrome. ( Sakane, N, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sakane, N | 1 |
| Mori, Y | 1 |
2 reviews available for mazindol and Metabolic Syndrome
| Article | Year |
|---|---|
Pharmacology in health foods:merits and demerits of food with health claims for the prevention of metabolic syndrome.
Topics: Anti-Obesity Agents; Consumer Health Information; Food, Organic; Humans; Japan; Mazindol; Metabolic | 2011 |
[Mazindol].
Topics: Appetite Depressants; Humans; Mazindol; Metabolic Syndrome; Obesity | 2011 |